Evidence map›Paper›PMID 29563336›Full record

ArticleJCI insight2018

Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.

David A Slatter, Charles L Percy, Keith Allen-Redpath, Joshua M Gajsiewicz, Nick J Brooks, Aled Clayton, Victoria J Tyrrell, Marcela Rosas, Sarah N Lauder, Andrew Watson and 11 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. The Biosynthesis of Enzymatically Oxidized Lipids.Frontiers in endocrinology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 3 countries.

David A SlatterSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Charles L PercySystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Keith Allen-RedpathSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Joshua M GajsiewiczDepartments of Biological Chemistry and Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Nick J BrooksFaculty of Natural Science, Department of Chemistry, Imperial College London, London, United Kingdom.
Aled ClaytonInstitute of Cancer and Genetics, Velindre Cancer Centre, School of Medicine, and.
Victoria J TyrrellSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Marcela RosasSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Sarah N LauderSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Andrew WatsonSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Maria DulSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.
Yoel Garcia-DiazSchool of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
Maceler AldrovandiSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Meike HeurichSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Judith HallSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
James H MorrisseyDepartments of Biological Chemistry and Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Sebastien Lacroix-DesmazesINSERM UMRS 1138, Centre de Recherche des Cordeliers, Paris, France.
Sandrine DelignatINSERM UMRS 1138, Centre de Recherche des Cordeliers, Paris, France.
P Vincent JenkinsHaematology Department, University Hospital of Wales, Cardiff, United Kingdom.
Peter W CollinsSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Valerie B O'DonnellSystems Immunity Research Institute and Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Cardiff University · GBInserm · FRUniversity of Michigan · USImperial College London · GBUniversity Hospital of Wales · GBVanderbilt University · USVelindre Cancer Centre · GB

Funding

Mechanisms in Blood ClottingR35HL135823 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORRISSEY, JAMES H. · 2017 to 2023
$4.8M
British Heart Foundation FS/11/42/28753British Heart Foundation RG/12/11/29815NHLBI NIH HHS R35 HL135823Wellcome TrustWellcome Trust 094143/Z/10/Z
6 · The paper itself

Abstract

Hemostatic defects are treated using coagulation factors; however, clot formation also requires a procoagulant phospholipid (PL) surface. Here, we show that innate immune cell-derived enzymatically oxidized phospholipids (eoxPL) termed hydroxyeicosatetraenoic acid-phospholipids (HETE-PLs) restore hemostasis in human and murine conditions of pathological bleeding. HETE-PLs abolished blood loss in murine hemophilia A and enhanced coagulation in factor VIII- (FVIII-), FIX-, and FX-deficient human plasma . HETE-PLs were decreased in platelets from patients after cardiopulmonary bypass (CPB). To explore molecular mechanisms, the ability of eoxPL to stimulate individual isolated coagulation factor/cofactor complexes was tested in vitro. Extrinsic tenase (FVIIa/tissue factor [TF]), intrinsic tenase (FVIIIa/FIXa), and prothrombinase (FVa/FXa) all were enhanced by both HETE-PEs and HETE-PCs, suggesting a common mechanism involving the fatty acid moiety. In plasma, 9-, 15-, and 12-HETE-PLs were more effective than 5-, 11-, or 8-HETE-PLs, indicating positional isomer specificity. Coagulation was enhanced at lower lipid/factor ratios, consistent with a more concentrated area for protein binding. Surface plasmon resonance confirmed binding of FII and FX to HETE-PEs. HETE-PEs increased membrane curvature and thickness, but not surface charge or homogeneity, possibly suggesting increased accessibility to cations/factors. In summary, innate immune-derived eoxPL enhance calcium-dependent coagulation factor function, and their potential utility in bleeding disorders is proposed.

Indexed as

AdultAgedAged, 80 and overAnimalsBlood CoagulationBlood Coagulation FactorsBlood PlateletsCardiopulmonary BypassCarrier ProteinsCysteine EndopeptidasesFactor IXFactor VIIaFactor VIIIFactor XHemophilia AHemorrhageBlood Coagulation Factorscancer procoagulantCarrier ProteinsCysteine EndopeptidasesF8 protein, humanFactor IXFactor VIIaFactor VIIIFactor XHydroxyeicosatetraenoic Acidslipoprotein-associated coagulation inhibitorLipoproteinsNeoplasm ProteinsPhospholipidsThrombinThromboplastinCoagulationHematology

Identifiers

PMID29563336
PMCPMC5926910
OpenAlexW2793947839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.